FDA 483 - Alan G. Garscadden, M.D. - July 21, 2023

An FDA inspection of Alan G. Garscadden, M.D. in Colorado Springs, CO, revealed a significant issue regarding the conduct of an investigation. The principal investigator failed to report all adverse events and medical history according to the study protocol. This indicates a lack of adherence to the investigational plan and signed statement of investigator.